News
Explore the most exciting new ideas and emerging concepts in science, health, technology and the environment with New Scientist鈥檚 exclusive in-depth articles, interviews and long reads.
Advertisement
Explore the most exciting new ideas and emerging concepts in science, health, technology and the environment with New Scientist鈥檚 exclusive in-depth articles, interviews and long reads.
An oral medicine called anastrozole has been approved by the UK's drug regulatory agency for reducing the risk of breast cancer in post-menopausal women at moderate-to-high risk of the condition
Part of the ITN Business programme 鈥楴utrition for Life鈥�, made in partnership with the British Nutrition Foundation.